Advertisement

Molecular Biology Reports

, Volume 46, Issue 6, pp 6413–6420 | Cite as

The effects of serum levels, and alterations in the genes of binding protein and receptor of vitamin D on gastric cancer

  • Şermin Durak
  • Arezoo Gheybi
  • Şeyda Demirkol
  • Soykan Arıkan
  • Ş. Ümit Zeybek
  • Filiz Akyüz
  • İlhan Yaylım
  • Özlem KüçükhüseyinEmail author
Original Article
  • 91 Downloads

Abstract

Due to many biological cell functions of vitamin D including regulation of cell survival, proliferation and differentiation, the metabolism of itself gains importance in the development of several types of cancer. This case–control study was designed to evaluate the risk of gastric cancer development in terms of VDR rs2228570 & rs731236, and VDBP rs7041 polymorphisms, and serum levels of vitamin D. The study consists of 77 gastric cancer patients and 84 healthy individuals. VDR and VDBP gene polymorphisms and vitamin D levels were determined by using PCR–RFLP and HPLC methods. The distribution of VDR or VDBP gene variants were not different in study groups. The serum level of 25-hydroxyvitamin D was significantly lower in gastric cancer patients versus controls (16 ± 6 → 11 ± 6 ng/ml) in which male patients have higher levels than females. Although the whole study population lacks normal levels of 25-hydroxyvitamin D, it was found that the risk of the development of gastric cancer was approximately fourfold higher in cases with severe vitamin D (< 10 ng/ml) deficiency. Our results indicate that VDR rs731236 & rs2228570 or VDBP rs7041 polymorphisms were not risk factors for the development of gastric cancer individually, however, lower serum levels of vitamin D may be a contributory risk for both predisposition and development of gastric cancer.

Keywords

Gastric cancer VDR VDBP Vitamin D Polymorphism 

Notes

Acknowledgements

The present study was supported by a grant from the Scientific Research Projects Coordination Unit of Istanbul University (Master of Science Project No: TYL-2018- 29205).

Compliance with ethical standards

Conflict of interests

The authors declare no conflict of interests.

References

  1. 1.
    Ferlay J, Steliarova-Foucher E, Lortet-Tieulent J, Rosso S, Coebergh JWW, Comber H et al (2013) Cancer incidence and mortality patterns in Europe: estimates for 40 countries in 2012. Eur J Cancer 49:1374–1403CrossRefGoogle Scholar
  2. 2.
    Siegel RL, Miller KD, Jemal A (2018) Cancer statistics, 2018. CA Cancer J Clin 68:7–30PubMedPubMedCentralGoogle Scholar
  3. 3.
    Devesa SS, Fraumeni JF Jr (1999) The rising incidence of gastric cardia cancer. J Natl Cancer Inst 91:747–749CrossRefGoogle Scholar
  4. 4.
    İrfan ŞEH, Murat G, Güledal B, Selin D (2014) TÜRKİYE KANSER İSTATİSTİKLERİGoogle Scholar
  5. 5.
    Stock M, Otto F (2005) Gene deregulation in gastric cancer. Gene 360:1–19CrossRefGoogle Scholar
  6. 6.
    Tsugane S, Sasazuki S (2007) Diet and the risk of gastric cancer: review of epidemiological evidence. Gastric Cancer 10:75–83CrossRefGoogle Scholar
  7. 7.
    Burnand B, Sloutskis D, Gianoli F, Cornuz J, Rickenbach M, Paccaud F et al (1992) Serum 25-hydroxyvitamin D: distribution and determinants in the Swiss population. Am J Clin Nutr 56:537–542CrossRefGoogle Scholar
  8. 8.
    Bao A, Li Y, Tong Y, Zheng H, Wu W, Wei C (2013) Tumor-suppressive effects of 1, 25-dihydroxyvitamin D3 in gastric cancer cells. Hepatogastroenterology 60:943–948PubMedGoogle Scholar
  9. 9.
    Baek S, Lee Y-S, Shim H-E, Yoon S, Baek S-Y, Kim B-S et al (2011) Vitamin D3 regulates cell viability in gastric cancer and cholangiocarcinoma. Anat Cell Biol 44:204–209CrossRefGoogle Scholar
  10. 10.
    Deeb KK, Trump DL, Johnson CS (2007) Vitamin D signalling pathways in cancer: potential for anticancer therapeutics. Nat Rev Cancer 7:684CrossRefGoogle Scholar
  11. 11.
    Speeckaert M, Huang G, Delanghe JR, Taes YE (2006) Biological and clinical aspects of the vitamin D binding protein (Gc-globulin) and its polymorphism. Clin Chim Acta 372:33–42CrossRefGoogle Scholar
  12. 12.
    Atoum MF, Tchoporyan MN (2014) Association between circulating vitamin D, the Taq1 vitamin D receptor gene polymorphism and colorectal cancer risk among Jordanians. Asian Pac J Cancer Prev 15:7337–7341CrossRefGoogle Scholar
  13. 13.
    Ren C, Qiu MZ, Wang DS, Luo HY, Zhang DS, Wang ZQ et al (2012) Prognostic effects of 25-hydroxyvitamin D levels in gastric cancer. J Transl Med 10:16CrossRefGoogle Scholar
  14. 14.
    Zhou L, Zhang X, Chen X, Liu L, Lu C, Tang X et al (2012) GC Glu416Asp and Thr420Lys polymorphisms contribute to gastrointestinal cancer susceptibility in a Chinese population. Int J Clin Exp Med 5:72PubMedPubMedCentralGoogle Scholar
  15. 15.
    Khayatzadeh S, Feizi A, Saneei P, Esmaillzadeh A (2015) Vitamin D intake, serum Vitamin D levels, and risk of gastric cancer: a systematic review and meta-analysis. J Res Med Sci 20:790CrossRefGoogle Scholar
  16. 16.
    Medlej-Hashim M, Jounblat R, Hamade A, Ibrahim JN, Rizk F, Azzi G et al (2015) Hypovitaminosis D in a young lebanese population: effect of GC gene polymorphisms on vitamin D and vitamin D binding protein levels. Ann Hum Genet 79:394–401CrossRefGoogle Scholar
  17. 17.
    Pan L, Matloob AF, Du J, Pan H, Dong Z, Zhao J et al (2010) Vitamin D stimulates apoptosis in gastric cancer cells in synergy with trichostatin A/sodium butyrate-induced and 5-aza-2′-deoxycytidine-induced PTEN upregulation. FEBS J 277:989–999CrossRefGoogle Scholar
  18. 18.
    Du C, Yang S, Zhao X, Dong H (2017) Pathogenic roles of alterations in vitamin D and vitamin D receptor in gastric tumorigenesis. Oncotarget 8:29474PubMedPubMedCentralGoogle Scholar
  19. 19.
    Holick MF, Binkley NC, Bischoff-Ferrari HA, Gordon CM, Hanley DA, Heaney RP, Murad MH, Weaver CM, Endocrine Society (2011) Evaluation, treatment, and prevention of vitamin D deficiency: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 96(7):1911–1930CrossRefGoogle Scholar
  20. 20.
    Knudson AG (2002) Cancer genetics. Am J Med Genet Part A 111:96–102CrossRefGoogle Scholar
  21. 21.
    Guggenheim DE, Shah MA (2013) Gastric cancer epidemiology and risk factors. J Surg Oncol 107:230–236CrossRefGoogle Scholar
  22. 22.
    Vyas N, Companioni RC, Tiba M, Alkhawam H, Catalano C, Sogomonian R et al (2016) Association between serum vitamin D levels and gastric cancer: a retrospective chart analysis. World J Gastrointest Oncol 8:688CrossRefGoogle Scholar
  23. 23.
    Eom SY, Yim DH, Kim DH, Yun HY, Song YJ (2018) Dietary vitamin D intake and vitamin D related genetic polymorphisms are not associated with gastric cancer in a hospital-based case-control study in Korea. J Biomed Res. 32(4):257–263PubMedPubMedCentralGoogle Scholar
  24. 24.
    Singh K, Gandhi S, Batool R (2018) A case-control study of the association between vitamin D levels and gastric incomplete intestinal metaplasia. Nutrients 10(5):629CrossRefGoogle Scholar
  25. 25.
    Rai V, Abdo J, Agrawal S, Agrawal DK (2017) Vitamin D receptor polymorphism and cancer: an update. Anticancer Res 37:3991–4003PubMedGoogle Scholar
  26. 26.
    Fang F, Gao J, Han F, Wang HJ (2016) Correlation of gastric cancer and effects of vitamin D receptor gene FokI polymorphism on C-reactive protein and D-dimer in Uygur nationality patients. Zhonghua Yi Xue Za Zhi 96(32):2541–2544PubMedGoogle Scholar
  27. 27.
    Parsamanesh N, Moossavi M, Tavakkoli T, Javdani H, Fakharian T, Moossavi SZ, Naseri M (2019) Positive correlation between vitamin D receptor gene TaqI variant and gastric cancer predisposition in a sample of Iranian population. J Cell Physiol.  https://doi.org/10.1002/jcp.28145 CrossRefPubMedGoogle Scholar
  28. 28.
    Haddad JG, Matsuoka LY, Hollis BW, Hu YZ, Wortsman J (1993) Human plasma transport of vitamin D after its endogenous synthesis. J Clin Investig 91:2552–2555CrossRefGoogle Scholar
  29. 29.
    Zhang Y, Wang X, Liu Y, Qu H, Qu S, Wang W et al (2012) The GC, CYP2R1 and DHCR1 genes are associated with vitamin D levels in northeastern Han Chinese children. Swiss Med Wkly 142:w13636PubMedGoogle Scholar
  30. 30.
    Sinotte M, Diorio C, Bérubé S, Pollak M, Brisson J (2008) Genetic polymorphisms of the vitamin D binding protein and plasma concentrations of 25-hydroxyvitamin D in premenopausal women–. Am J Clin Nutr 89:634–640CrossRefGoogle Scholar
  31. 31.
    Kitanaka S, Isojima T, Takaki M, Numakura C, Hayasaka K, Igarashi T (2012) Association of vitamin D-related gene polymorphisms with manifestation of vitamin D deficiency in children. Endocr J 59:1007–1014CrossRefGoogle Scholar
  32. 32.
    Gozdzik A, Zhu J, Wong BYL, Fu L, Cole DE, Parra EJ (2011) Association of vitamin D binding protein (VDBP) polymorphisms and serum 25 (OH) D concentrations in a sample of young Canadian adults of different ancestry. J Steroid Biochem Mol Biol 127:405–412CrossRefGoogle Scholar
  33. 33.
    Venerito M, Link A, Rokkas T, Malfertheiner P (2016) Gastric cancer—clinical and epidemiological aspects. Helicobacter 21:39–44CrossRefGoogle Scholar
  34. 34.
    Yamamoto N, Suyama H, Yamamoto N (2008) Immunotherapy for prostate cancer with Gc protein-derived macrophage-activating factor; GcMAF. Transl Oncol 1:65–72CrossRefGoogle Scholar

Copyright information

© Springer Nature B.V. 2019

Authors and Affiliations

  1. 1.Department of Molecular MedicineAziz Sancar Institute of Experimental Medicine, Istanbul UniversityIstanbulTurkey
  2. 2.General Surgery ClinicsIstanbul Educating and Training HospitalIstanbulTurkey
  3. 3.Vocational School of Health ServicesBiruni UniversityIstanbulTurkey
  4. 4.Department of Gastroenterology, Istanbul Faculty of MedicineIstanbul UniversityIstanbulTurkey

Personalised recommendations